Anidulafungin Treatment of Candidal Central Nervous System Infection in a Murine Model

  • Kang, Cheol-In; 
  • Rouse, Mark S.; 
  • Mandrekar, Jayawant N.; 
  • Steckelberg, James M.; 
  • Patel, Robin
Citations

WEB OF SCIENCE

12
Citations

SCOPUS

14

초록

We established a murine model of Candida albicans central nervous system (CNS) infection and evaluated the efficacy of anidulafungin. Ten milligrams/kg/day anidulafungin, amphotericin B, or voriconazole significantly reduced mortality and fungal burden in brain tissue, although amphotericin B and 10 mg/kg/day anidulafungin reduced fungal burden in brain tissue to a greater extent than did voriconazole. This suggests a potential role for anidulafungin in the treatment of candidal CNS infection.

키워드

CLINICAL-TRIALS; AMPHOTERICIN-B; VORICONAZOLE; CANDIDIASIS; PHARMACOKINETICS; ECHINOCANDIN; CASPOFUNGIN; MICAFUNGIN; EFFICACY
제목
Anidulafungin Treatment of Candidal Central Nervous System Infection in a Murine Model
저자
Kang, Cheol-In; Rouse, Mark S.; Mandrekar, Jayawant N.; Steckelberg, James M.; Patel, Robin
DOI
10.1128/AAC.00646-09
발행일
2009-08
유형
Article
저널명
Antimicrobial Agents and Chemotherapy
권
53
호
8
페이지
3576 ~ 3578